[Construction of evidence graph for modifiable risk factors for diabetic retinopathy].

Q1 Medicine
S Y Shi, Q X Zhou, H Y Sun, S Y Zhan, F Sun, S Y Zhang
{"title":"[Construction of evidence graph for modifiable risk factors for diabetic retinopathy].","authors":"S Y Shi, Q X Zhou, H Y Sun, S Y Zhan, F Sun, S Y Zhang","doi":"10.3760/cma.j.cn112338-20240425-00217","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> Diabetic retinopathy (DR) has been reported as the leading cause of blindness among diabetic adults, which is closely related to poor quality of life and increased burden of disability. This study aimed to aggregate the optimally available evidence on modifiable risks of DR. <b>Methods:</b> Until June 2023, PubMed, Cochrane Library, CNKI, and Wanfang databases were used to retrieve Meta-analysis about various risk factors for DR, and Meta-analysis were analyzed and summarized. R 4.3.2 software was used for each Meta-analytic association to calculate the effect size, 95%<i>CI</i>, heterogeneity, small-study effects, excess significance bias, and 95% prediction intervals. The credibility of significant evidence was graded. <b>Results:</b> We captured 23 eligible papers (72 associations) covering a wide range of medication use, concomitant diseases, daily intervention, biomarkers, lifestyle, and physical measurement index. Among them, higher HbA1c variability (<i>RR</i>=1.45, 95%<i>CI</i>: 1.26-1.66) and urine microalbumin positive (<i>OR</i>=2.44, 95%<i>CI</i>: 1.99-2.97) were convincing (grade Ⅰ) evidence, and insulin use (<i>RR</i>=3.48, 95%<i>CI</i>: 2.14-5.67) was highly suggestive (grade Ⅱ) evidence. Moreover, hypertension (<i>OR</i>=2.03, 95%<i>CI</i>: 1.06-3.97), poor glycemic control (<i>OR</i>=4.35, 95%<i>CI</i>: 1.47-12.85), positive macroalbuminuria (<i>OR</i>=8.42, 95%<i>CI</i>: 3.52-20.15), long sleep duration (<i>OR</i>=2.05, 95%<i>CI</i>: 1.37-3.05), vitamin D deficiency (<i>OR</i>=2.02, 95%<i>CI</i>: 1.17-3.50), periodontitis (<i>OR</i>=4.51, 95%<i>CI</i>: 1.76-11.55) were the main risk factors for DR. Intensive blood pressure intervention (<i>RR</i>=0.78, 95%<i>CI</i>: 0.65-0.94), dietary control (<i>OR</i>=0.64, 95%<i>CI</i>: 0.47-0.89) and moderate intensity physical activity (<i>RR</i>=0.76, 95%<i>CI</i>: 0.59-0.97) yielded significant protective associations with DR. <b>Conclusions:</b> Intensive blood pressure glycemic control, and a healthy lifestyle pattern could reduce the risk of DR. This study provides the evidence to identify high-risk populations and recommends rational treatment options and healthy living interventions.</p>","PeriodicalId":23968,"journal":{"name":"中华流行病学杂志","volume":"45 12","pages":"1736-1744"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华流行病学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112338-20240425-00217","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Diabetic retinopathy (DR) has been reported as the leading cause of blindness among diabetic adults, which is closely related to poor quality of life and increased burden of disability. This study aimed to aggregate the optimally available evidence on modifiable risks of DR. Methods: Until June 2023, PubMed, Cochrane Library, CNKI, and Wanfang databases were used to retrieve Meta-analysis about various risk factors for DR, and Meta-analysis were analyzed and summarized. R 4.3.2 software was used for each Meta-analytic association to calculate the effect size, 95%CI, heterogeneity, small-study effects, excess significance bias, and 95% prediction intervals. The credibility of significant evidence was graded. Results: We captured 23 eligible papers (72 associations) covering a wide range of medication use, concomitant diseases, daily intervention, biomarkers, lifestyle, and physical measurement index. Among them, higher HbA1c variability (RR=1.45, 95%CI: 1.26-1.66) and urine microalbumin positive (OR=2.44, 95%CI: 1.99-2.97) were convincing (grade Ⅰ) evidence, and insulin use (RR=3.48, 95%CI: 2.14-5.67) was highly suggestive (grade Ⅱ) evidence. Moreover, hypertension (OR=2.03, 95%CI: 1.06-3.97), poor glycemic control (OR=4.35, 95%CI: 1.47-12.85), positive macroalbuminuria (OR=8.42, 95%CI: 3.52-20.15), long sleep duration (OR=2.05, 95%CI: 1.37-3.05), vitamin D deficiency (OR=2.02, 95%CI: 1.17-3.50), periodontitis (OR=4.51, 95%CI: 1.76-11.55) were the main risk factors for DR. Intensive blood pressure intervention (RR=0.78, 95%CI: 0.65-0.94), dietary control (OR=0.64, 95%CI: 0.47-0.89) and moderate intensity physical activity (RR=0.76, 95%CI: 0.59-0.97) yielded significant protective associations with DR. Conclusions: Intensive blood pressure glycemic control, and a healthy lifestyle pattern could reduce the risk of DR. This study provides the evidence to identify high-risk populations and recommends rational treatment options and healthy living interventions.

【糖尿病视网膜病变可改变危险因素的证据图构建】。
目的:糖尿病视网膜病变(DR)已被报道为糖尿病成人致盲的主要原因,其与生活质量差和残疾负担增加密切相关。方法:截至2023年6月,利用PubMed、Cochrane图书馆、中国知网和万方数据库检索DR各种危险因素的meta分析,并对meta分析进行分析和总结。每个meta分析关联使用r4.3.2软件计算效应大小、95% ci、异质性、小研究效应、过度显著性偏差和95%预测区间。对重要证据的可信度进行分级。结果:我们收集了23篇符合条件的论文(72个协会),涵盖了广泛的药物使用、伴随疾病、日常干预、生物标志物、生活方式和身体测量指标。其中,较高的HbA1c变异性(RR=1.45, 95%CI: 1.26-1.66)和尿微量白蛋白阳性(OR=2.44, 95%CI: 1.99-2.97)是令人信服的证据(等级Ⅰ),使用胰岛素(RR=3.48, 95%CI: 2.14-5.67)是高度提示性的证据(等级Ⅱ)。此外,高血压(OR=2.03, 95%CI: 1.06-3.97)、血糖控制不良(OR=4.35, 95%CI: 1.47-12.85)、大量蛋白尿阳性(OR=8.42, 95%CI: 3.52-20.15)、睡眠时间长(OR=2.05, 95%CI: 1.37-3.05)、维生素D缺乏(OR=2.02, 95%CI: 1.17-3.50)、牙周炎(OR=4.51, 95%CI: 1.76-11.55)是dr的主要危险因素。强化血压干预(RR=0.78, 95%CI: 0.65-0.94)、饮食控制(OR=0.64, 95%CI: 0.94)是dr的主要危险因素。0.47-0.89)和中等强度体力活动(RR=0.76, 95%CI: 0.59-0.97)与dr具有显著的保护性关联。结论:强化血压血糖控制和健康的生活方式模式可降低dr的风险。本研究为识别高危人群、推荐合理的治疗方案和健康生活干预提供了证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中华流行病学杂志
中华流行病学杂志 Medicine-Medicine (all)
CiteScore
5.60
自引率
0.00%
发文量
8981
期刊介绍: Chinese Journal of Epidemiology, established in 1981, is an advanced academic periodical in epidemiology and related disciplines in China, which, according to the principle of integrating theory with practice, mainly reports the major progress in epidemiological research. The columns of the journal include commentary, expert forum, original article, field investigation, disease surveillance, laboratory research, clinical epidemiology, basic theory or method and review, etc.  The journal is included by more than ten major biomedical databases and index systems worldwide, such as been indexed in Scopus, PubMed/MEDLINE, PubMed Central (PMC), Europe PubMed Central, Embase, Chemical Abstract, Chinese Science and Technology Paper and Citation Database (CSTPCD), Chinese core journal essentials overview, Chinese Science Citation Database (CSCD) core database, Chinese Biological Medical Disc (CBMdisc), and Chinese Medical Citation Index (CMCI), etc. It is one of the core academic journals and carefully selected core journals in preventive and basic medicine in China.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信